Emmet B. Keeffe

Emmet B. Keeffe's AcademicInfluence.com Rankings

Emmet B. Keeffe

Philosophy

#6673

World Rank

#9748

Historical Rank

Logic

#3806

World Rank

#5017

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Emmet B. Keeffe's Degrees

Doctorate Medicine Harvard University

Why Is Emmet B. Keeffe Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Emmet B. Keeffe's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. (2008) (562)
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. (2006) (428)
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. (2004) (424)
Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. (2001) (324)
Hepatitis B virus genotypes in the United States: results of a nationwide study. (2003) (316)
Validation of a recording spectrophotometric method for measurement of membrane-associated Mg- and NaK-ATPase activity. (1979) (313)
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B. (2007) (276)
Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? (1995) (262)
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease (1998) (261)
Management of Antiviral Resistance in Patients with Chronic Hepatitis B (2004) (253)
Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. (1998) (245)
Liver transplantation: current status and novel approaches to liver replacement. (2001) (225)
Prevalence of HBV precore/core promoter variants in the United States (2003) (225)
Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. (2005) (210)
Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. (2005) (208)
Health-related quality of life after liver transplantation: a meta-analysis. (1999) (205)
1989 A/S/G/E survey of endoscopic sedation and monitoring practices. (1990) (192)
Development and evaluation of the liver disease quality of life instrument in persons with advanced, chronic liver disease—the LDQOL 1.0 (2000) (183)
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. (1997) (181)
Racial differences in effectiveness of α‐fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis (2002) (173)
Re‐treatment of chronic hepatitis C with consensus interferon (1998) (172)
Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. (1999) (171)
Cost‐effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C (2004) (164)
Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin. (2009) (147)
Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients (1996) (140)
Liver transplantation for patients with alcoholism and end-stage liver disease. (1993) (135)
Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation (2009) (131)
Viral Hepatitis and Other Infectious Diseases in a Homeless Population (2002) (128)
Tuberculosis in liver transplant recipients: A systematic review and meta‐analysis of individual patient data (2009) (124)
Systematic review: lamivudine prophylaxis for chemotherapy‐induced reactivation of chronic hepatitis B virus infection (2006) (124)
Review article: current antiviral therapy of chronic hepatitis B (2011) (124)
Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes. (2003) (118)
Transjugular liver biopsy (1992) (117)
Management of biliary complications after liver transplantation. (1992) (116)
An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. (2010) (114)
Outcome of liver transplantation in patients with hemochromatosis (1994) (112)
Liver transplantation for alcoholic liver disease: Current concepts and length of sobriety (2004) (112)
Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection (2005) (109)
General management. (2005) (106)
Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. (1992) (104)
Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. (2005) (100)
Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection (1999) (98)
Neurological complications of liver transplantation in adult versus pediatric patients. (1994) (96)
Older age and liver transplantation: A review (2004) (95)
Hepatitis vaccination in patients with chronic liver disease (2004) (94)
Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation (2010) (94)
Therapy of hepatitis C: Consensus interferon trials (1997) (94)
Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. (1995) (93)
Gastrointestinal symptoms of marathon runners. (1984) (92)
Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: A systematic review (2001) (90)
Alteration of rat liver plasma membrane fluidity and ATPase activity by chlorpromazine hydrochloride and its metabolites. (1980) (89)
Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination. (2005) (88)
Current indications and contraindications for liver transplantation. (2007) (87)
Allograft rejection after liver transplantation for autoimmune liver diseases. (1998) (86)
Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence? (2003) (85)
Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. (2001) (85)
Detection and treatment of coronary artery disease in liver transplant candidates (2001) (84)
Are infectious agents involved in primary biliary cirrhosis? A PCR approach. (1999) (83)
Clinical course of hepatitis B virus infection during pregnancy (2009) (82)
Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies (2003) (79)
Nonalcoholic fatty liver disease. (2002) (79)
Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. (2004) (78)
Survival after liver transplantation in patients with hepatic iron overload (2005) (78)
Chronic hepatitis B: preventing, detecting, and managing viral resistance. (2008) (78)
Treatment of severe reflux esophagitis with cimetidine and metoclopramide. (1986) (77)
Detection and surveillance of colorectal cancer. (1989) (77)
Response to dopamine hydrochloride in the hepatorenal syndrome. (1975) (74)
The Epidemiology of Hepatitis C Virus Infection (2003) (74)
Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels. (2008) (74)
Liver Biopsy for Histological Assessment – The Case Against (2010) (73)
Liver transplantation in patients with severe obesity. (1994) (70)
Keratins as susceptibility genes for end-stage liver disease. (2005) (70)
Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus DNA, and Normal Alanine Aminotransferase Levels (2009) (69)
Treatment strategies for chronic hepatitis C: Update since the 1997 National Institutes of Health Consensus Development Conference (1999) (66)
Comparison of transjugular and surgical portosystemic shunts on the outcome of liver transplantation. (1994) (66)
Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation. (2001) (65)
High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy (2012) (65)
Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. (2006) (65)
Erythropoietic Response to Anemia in Chronic Hepatitis C Patients Receiving Combination Pegylated Interferon/Ribavirin (2005) (63)
Management of gallstones and their complications. (2000) (62)
Current treatment strategies for chronic hepatitis B and C. (2001) (61)
Review article: hepatitis vaccination in patients with chronic liver disease. (2004) (60)
Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy. (2007) (57)
Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. (2007) (57)
Lupus meningitis. Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid. (1974) (57)
Training the gastroenterologist of the future: the gastroenterology core curriculum. The Gastroenterology Leadership Council. (1996) (56)
Screening for Hepatocellular Carcinoma (2002) (56)
Review article: current antiviral therapy of chronic hepatitis B (2008) (55)
Management of hepatocellular carcinoma. (2003) (54)
Higher Rate of Sustained Virologic Response in Chronic Hepatitis C Genotype 6 Treated With 48 Weeks Versus 24 Weeks of Peginterferon Plus Ribavirin (2008) (54)
Chronic hepatitis B: early viral suppression and long‐term outcomes of therapy with oral nucleos(t)ides (2009) (53)
Immunopathogenesis of primary biliary cirrhosis. (1999) (53)
Prolonged cholestasis due to trimethoprim sulfamethoxazole. (1992) (53)
Chronic hepatitis C with normal aminotransferase levels. (2004) (53)
Chronic hepatitis B and hepatitis C in Asian Americans. (2003) (50)
Chronic hepatitis C: genotypes 4 to 9. (2005) (50)
High rate of unemployment after liver transplantation: Analysis of the United Network for Organ Sharing database (2012) (49)
Hepatitis B vaccination of patients with chronic liver disease. (1998) (48)
Summary of guidelines on organ allocation and patient listing for liver transplantation. (1998) (48)
An algorithm for the management of hepatic encephalopathy (2007) (48)
Impact of Age Older Than 60 Years in Living Donor Liver Transplantation (2007) (48)
Patterns of hepatitis C viremia in patients receiving hemodialysis. (1997) (47)
Hepatitis B vaccines. (2004) (47)
In vitro effect of bile salts on rat liver plasma membrane, lipid fluidity, and ATPase activity (1981) (47)
Primary liver transplantation without transfusion of red blood cells. (1996) (47)
Prophylaxis Against Chemotherapy-Induced Reactivation of Hepatitis B Virus Infection With Lamivudine (2003) (46)
New and emerging treatment of chronic hepatitis B. (2007) (46)
Diabetes Mellitus Increases the Risk of Mortality Following Liver Transplantation Independent of MELD Score (2010) (45)
Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C. (2008) (45)
Quality of life and employment after liver transplantation (2001) (45)
Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides. (2009) (44)
Treatment of Chronic Hepatitis C Using a 4-week Lead-in With Nitazoxanide Before Peginterferon Plus Nitazoxanide (2009) (42)
Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group. (1997) (41)
Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection (2011) (41)
Helicobacter pylori infection and blood group antigens: lack of clinical association. (1996) (39)
Orthotopic liver transplantation for hepatocellular carcinoma. Factors affecting long-term patient survival. (1996) (39)
Long-term follow-up after liver transplantation in patients with hepatic iron overload. (1999) (38)
Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy. (2011) (37)
Chronic hepatitis B: a critical appraisal of current approaches to therapy. (2006) (34)
Pseudomembranous enterocolitis. Resurgence related to newer antibiotic therapy. (1974) (34)
Hepatotoxicity of transplant immunosuppressive agents. (1995) (34)
Occupational risk for hepatitis A: a literature-based analysis. (2004) (34)
Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9. (2004) (33)
Handbook of Liver Disease (2011) (33)
Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression. (1995) (33)
Liver transplantation in Asian patients with chronic hepatitis B (1997) (32)
Liver transplantation: evolving patient selection criteria. (2001) (32)
Pancreatic insufficiency associated with ulcerative colitis and pericholangitis. (1982) (32)
Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration (1999) (31)
Disulfiram hypersensitivity hepatitis. (1974) (31)
Steatosis and cirrhosis in an obese diabetic. Resolution of fatty liver by fasting. (1987) (31)
Colonoscopy preps: what's best? (1996) (31)
Sarcoidosis and primary biliary cirrhosis. Literature review and illustrative case. (1987) (31)
Sedation and analgesia for endoscopy. (1995) (31)
New approaches to supporting the failing liver. (1998) (30)
Isolated Aspartate Aminotransferase Elevation: Think Macro-AST (2011) (30)
Liver transplantation for treatment of giant hepatocellular adenomas. (1995) (30)
Digestive Diseases and Sciences—Past, Present, and Future (2008) (29)
Diagnosis and treatment of chronic hepatitis B: 2009 update. (2009) (29)
Fulminant hepatic failure secondary to neoplastic infiltration of the liver. (2005) (28)
T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity. (2005) (28)
Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation (1994) (28)
Is Oral l-Acyl-Carnitine an Effective Therapy for Hepatic Encephalopathy? Review of the Literature (2008) (28)
Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy (2001) (28)
Clinical outcome after percutaneous transhepatic obliteration of esophageal varices. (1983) (28)
A novel technique for endoscopic removal of expandable biliary Wallstent. (1999) (27)
Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B (2009) (27)
Hepatitis A in patients with chronic liver disease – severity of illness and prevention with vaccination (2000) (27)
Hepatitis B vaccines. (2006) (27)
Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy. (2011) (26)
Resection versus transplantation for hepatocellular carcinoma (1999) (26)
Employment after liver transplantation: a review. (2015) (26)
IL-28B As a Predictor of Sustained Virologic Response in Patients with Chronic Hepatitis C Virus Infection. (2011) (26)
Do we still need a liver biopsy? Are the serum fibrosis tests ready for prime time? (2006) (25)
Liver transplantation in patients with hepatitis B virus infection: Outcome in asian versus white patients (2001) (25)
Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group. (1997) (24)
Hepatitis G virus: is it a hepatitis virus? (1997) (24)
End‐stage liver disease and liver transplantation: Role of lamivudine therapy in patients with chronic hepatitis B (2000) (24)
Endoscopic gastrointestinal manifestations of liver disease. (2001) (23)
68 RANDOMIZED CONTROLLED TRIAL OF NITAZOXANIDE-PEGINTERFERON-RIBAVIRIN, NITAZOXANIDE-PEGINTERFERON AND PEGINTERFERON-RIBAVIRIN IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 4 (2008) (23)
Acute pancreatitis after gastrointestinal endoscopy. (2002) (23)
Role of liver biopsy in the management of chronic liver disease: selective rather than routine. (2005) (23)
Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C (2010) (23)
Hepatocellular carcinoma in arteriohepatic dysplasia. (1993) (22)
Liver transplantation at the millennium. Past, present, and future. (2000) (22)
Isolated metastasis to small bowel from anaplastic thyroid carcinoma. With a review of extra-abdominal malignancies that spread to the bowel. (1987) (22)
Patient selection and listing policies for liver transplantation (1999) (21)
Esophageal burn and the microwave oven. (1982) (21)
Study of adherence comes to the treatment of chronic hepatitis B. (2011) (20)
Are hepatitis B e antigen (HBeAg)-positive chronic hepatitis B and HBeAg-negative chronic hepatitis B distinct diseases? (2008) (19)
Chronic hepatitis C: management of treatment failures. (2005) (19)
Comorbidities of alcoholic liver disease that affect outcome of orthotopic liver transplantation. (1997) (19)
Steatosis and cirrhosis in an obese diabetic (1987) (18)
Long‐term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion (2007) (18)
Atlas of Gastrointestinal Endoscopy (1998) (18)
Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection (1998) (18)
Acute pancreatitis associated with acute hepatitis A. (1992) (18)
Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients (2012) (18)
An appraisal of patients' reactions to "informed consent" for peroral endoscopy. (1977) (18)
Severe and prolonged oral contraceptive jaundice. (1984) (18)
Peginterferon vs. standard interferon in the treatment of chronic hepatitis C (2003) (17)
Isolation of a rat liver plasma membrane fraction of probable canalicular origin. Preparative technique, enzymatic profile, composition, and solute transport. (1981) (17)
Diagnosis of sclerosing cholangitis with technetium 99m-labeled iminodiacetic acid planar and single photon emission computed tomographic scintigraphy. (1987) (17)
Asymptomatic elevation of aminotransferase levels and fatty liver secondary to heterozygous hypobetalipoproteinemia (1998) (17)
Risk of tuberculosis in tuberculin skin test-positive liver transplant patients. (1999) (16)
Management of variceal hemorrhage in the potential liver transplant candidate. (1989) (16)
Clinical outcomes of liver transplantation for HBV‐related hepatocellular carcinoma: data from the NIH HBV OLT study (2011) (16)
Diagnosis and treatment of primary biliary cirrhosis. (2000) (16)
Future Treatment of Chronic Hepatitis C (2007) (15)
Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate (1982) (15)
Assessment of the alcoholic patient for liver transplantation: comorbidity, outcome, and recidivism. (1996) (15)
Liver transplantation for uncontrollable variceal bleeding. (1994) (15)
Pulmonary varices presenting as a solitary lung mass in a patient with end-stage liver disease. (1994) (15)
High Rate of Complete Viral Suppression With Combination Therapy in Patients With Chronic Hepatitis B and Prior Treatment Failure (2011) (14)
Quality of life, employment, and alcohol consumption after liver transplantation (2001) (14)
Pathogenesis of primary biliary cirrhosis. (2003) (14)
Chapter Thirty-Six – Alcoholic and nonalcoholic fatty liver disease (2006) (13)
Management of the pregnant hepatitis B patient (2008) (13)
Scintigraphic Criteria for the Diagnosis of Obstructive Hepatobiliary Diseases with Tc-99m IDA (1988) (13)
Serum gamma-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapy (1986) (13)
Screening flexible sigmoidoscopy by primary care physicians. Effectiveness and costs in patients negative for fecal occult blood. (1986) (13)
Primary sclerosing cholangitis in ulcerative colitis. (1985) (13)
Diagnosis and treatment of chronic hepatitis B. (2004) (13)
Sclerotherapy versus banding in the treatment of variceal bleeding. (1997) (13)
Management of chronic hepatitis C treatment failures: role of consensus interferon (2009) (13)
Hematologic side effects of PEG interferon and ribavirin. Management with growth factors. (2005) (13)
Recurrent obstructive jaundice caused by fibrolamellar hepatocellular carcinoma (1984) (12)
Living donor liver transplantation in a patient with hepatic epithelioid hemangioendothelioma. (2003) (12)
Aortoduodenal fistula: complication of renal artery bypass graft. (1974) (12)
1049 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF NITAZOXANIDE PLUS PEGINTERFERON AND RIBAVIRIN IN HCV GENOTYPE 1 PATIENTS: INTERIM ANALYSIS SHOWS INCREASE IN EVR (2009) (12)
Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant period. (2003) (12)
Portal hypertensive hemorrhage from a left gastroepiploic vein caput medusa in an adhesed umbilical hernia. (2005) (11)
Primary biliary cirrhosis: Tc-99m IDA planar and SPECT scanning. (1988) (11)
Hepatitis C virus and liver transplantation. (2001) (11)
Antibiotics in the management of hepatic encephalopathy: an evidence-based review. (2005) (11)
Liver transplantation for alcoholic liver disease: selection and outcome. (1997) (11)
Overview of interferon therapy for chronic hepatitis C. (1999) (11)
Controversies in patient selection for liver transplantation. (1993) (11)
Therapy for collagenous colitis. (1987) (10)
EVALUATION OF MILDLY ABNORMAL LIVER TESTS IN ASYMPTOMATIC PATIENTS (1990) (10)
Entecavir for the long-term treatment of chronic hepatitis B (2009) (10)
Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy. (2001) (10)
Outcomes and effectiveness research: the 1992 investigator conference of the American Society for Gastrointestinal Endoscopy. (1993) (10)
Milestones in liver transplantation for alcoholic liver disease. (1997) (10)
Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection (2011) (10)
Hematologic manifestations of gastrointestinal disease. (1987) (10)
Acute appendicitis secondary to metastatic cholangiocarcinoma. (1993) (9)
Diagnosis and treatment of chronic hepatitis B: an update. (2007) (9)
2001 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF NITAZOXANIDE PLUS PEGINTERFERON AND RIBAVIRIN IN HCV GENOTYPE 1 NAIVE PATIENTS: WEEK 12 SUSTAINED VIROLOGIC RESPONSE RATE (2010) (9)
832 EVALUATION OF A 4 WEEK LEAD-IN PHASE WITH NITAZOXANIDE PRIOR TO NITAZOXANIDE+PEGINTERFERON IN TREATING CHRONIC HEPATITIS C (2008) (9)
Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B (2009) (9)
Hepatitis B: modern end points of treatment and the specter of viral resistance. (2011) (9)
Management of chronic hepatitis B in challenging patient populations (2006) (9)
1188 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF NITAZOXANIDE WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN NONRESPONDERS (NR) WITH CHRONIC HEPATITIS C GENOTYPE 1: FINAL REPORT (2010) (9)
Diabetes and the hepatobiliary system. (1998) (9)
S2075 Prevalence of HBV DNA Polymerase (B-DNA Pol) Mutations in 345 Patients with Treatment-NaïVe Chronic Hepatitis B (CHB) (2008) (9)
Colonic lymphoma in the transplant patient (2005) (8)
Cost-effective evaluation of acute viral hepatitis. (2000) (8)
Risk assessment for hepatocellular carcinoma in chronic hepatitis B: scores and surveillance (2012) (8)
Chronic hepatitis B with advanced fibrosis or cirrhosis: impact of antiviral therapy. (2007) (8)
Liver transplantation in patients with hepatic iron overload: Favorable or unfavorable outcome? (2000) (8)
The immunopathology of primary biliary cirrhosis: thoughts for the millennium. (2000) (8)
1059 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF NITAZOXANIDE WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN NONRESPONDERS (NR) WITH CHRONIC HCV GENOTYPE 1: WEEK 28 INTERIM ANALYSIS (2009) (8)
Hepatitis B: explosion of new knowledge. (2007) (8)
Management of chronic liver failure until liver transplantation. (2008) (8)
Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C. Consensus Interferon Study Group. (1999) (7)
Initial two-year results of the Oregon Liver Transplantation Program. (1991) (7)
Ruptured abdominal aortic aneurysm causing obstructive jaundice (2005) (7)
Hepatitis G virus: clinical relevance and responsiveness to interferon. (1997) (7)
Adenomatous polyp arising in Barrett's esophagus. (1986) (7)
Retreatment of chronic hepatitis C virus infection. (2004) (6)
Utility of hepatitis C virus serotypes in predicting response to treatment of chronic hepatitis C. Consensus Interferon Study Group. (1999) (6)
Diabetic gastroparesis. (1995) (6)
SIGNIFICANCE OF MILDLY ELEVATED LIVER TESTS ON SCREENING BIOCHEMISTRY PROFILES (1990) (6)
Technical Monitoring During Radiologic Interventions — What Can Be Done and What Must Be Done (1993) (6)
Advances in liver disease. Highlights from the 51st Annual Meeting of the American Association for the Study of Liver Diseases, October 27-31, 2000, Dallas, TX. (2001) (6)
Advances in gastrointestinal pharmacotherapy. (2005) (6)
Aortic valve endocarditis after orthotopic liver transplantation. (1994) (6)
Primary biliary cirrhosis: lessons learned from an organ-specific disease. (2001) (6)
Peginterferons in hepatitis C virus: virological, pharmacokinetic, and clinical implications. Introduction. (2003) (6)
Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis. (2001) (5)
Recent developments in the treatment of chronic hepatitis B virus infection (1995) (5)
Advancing the Clinical Treatment of Hepatitis B Virus (2005) (5)
Long‐term management of the liver transplant patient (2001) (5)
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide Plus Peginterferon and Ribavirin in Naïve Patients With Chronic Hepatitis C Genotype 1 Infection: Final Report (2010) (5)
Hypoglycemic coma in a pregnant woman in association with hepatitis B virus carrier state and hepatocellular carcinoma. (2004) (5)
NAFLD and NASH: Important diseases before and after liver transplantation (2001) (5)
Long-Term Effects of Antiviral Therapy in Patients with Chronic Hepatitis C (2010) (5)
Ileal volvulus following colonoscopy. (1985) (5)
831 RANDOMIZED DOUBLE BLIND PLACEBO-CONTROLLED TRIAL OF NITAZOXANIDE IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 4 (2008) (5)
Clinical approach to viral hepatitis in homosexual men. (1986) (5)
A review of the use of telbivudine in the treatment of chronic hepatitis B (2009) (4)
Patient selection criteria for liver transplantation. (2003) (4)
Risk score for development of HCC: ready for use in practice? (2011) (4)
Hepatitis B virus reactivation with chemotherapy: diagnosis and prevention with antiviral prophylaxis. (2004) (4)
Prednisone withdrawal advocates: Beware of recurrent autoimmune hepatitis (1999) (4)
IS LAMIVUDINE BENEFICIAL IN HBSAG+ PATIENTS AWAITING LIVER TRANSPLANTATION? EXPERIENCE IN 182 NORTH AMERICAN PATIENTS. (1999) (4)
Relationship between physical and functional properties of canaliculi-enriched liver plasma membranes (LPM) and canalicular bile flow (1978) (4)
Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance (2008) (4)
1014 Evaluation and outcomes of combination therapy with interferon or peginterferon plus ribavirin in 67 Southeast Asian patients with hepatitis C genotypes 6, 7, 8, and 9 (2003) (4)
IL-28 B As a Predictor of Sustained Virologic Response in Patients with Chronic Hepatitis C Virus Infection (2013) (3)
Endoscopic Procedural Safety (1991) (3)
Taurocholate: A rapid regulator of canalicular hembrane NaK-ATPase activity (1978) (3)
Psychological assessment of quality of life following liver transplantation (1994) (3)
Handbook of Liver Disease, 3rd Edition Expert Consult - Online and Print (2011) (3)
Chapter 2 – Acute liver failure (2004) (3)
Erythropoietic response to anemia is decreased in patients infected with hepatitis C virus (HCV) receiving combination ribavirin and pegylated interferon (RBV/PEG-IFN) therapy (2003) (3)
The successful use of telemedicine in acute variceal hemorrhage. (1999) (3)
Antibiotic Prophylaxis: Who, When, and How (1993) (3)
Differential diagnosis of gallstone-induced complications. (2000) (3)
Treatment of Chronic Hepatitis B (CHB) with Nitazoxanide (Ntz) Alone or Ntz Plus Adefovir (ADV) for Two Years with Loss of Hepatitis B E Antigen (HBeAg) and Hepatitis B Surface Antigen (HbsAg): Report of Two Cases (2008) (3)
Prevalence of HBV precore and core promotor variants in the United States — results of a nation-wide study (2002) (3)
HEPATOLOGY: A CENTURY OF PROGRESS LIVER TRANSPLANTATION AT THE MILLENNIUM Past, Present and Future (2000) (3)
Best of the AASLD. Highlights from the 52nd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2001, Dallas, TX. (2002) (3)
Chapter 49 – Pretransplant Evaluation and Care (2006) (3)
Impact of organ shortage on liver transplantation (2001) (3)
Trichobezoar associated with gastric polyposis. (1988) (3)
Liver transplantation at California Pacific Medical Center, San Francisco, California. (1994) (3)
Comparative effects of blood, colloid, and Ringer's lactate terminal allograft rinse on the results of orthotopic liver transplantation. (1993) (3)
Association of Hepatocellular Carcinoma (HCC) With Hepatitis B Virus (HBV) Versus Hepatitis C Virus (HCV) Infection Among Different Asian Subgroups (2011) (2)
Annals of Clinical Microbiology and Anti microbials (2005) (2)
The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults. (2007) (2)
Chronic hepatitis B and C: update on therapy (2009) (2)
Liver transplantation in elderly patients (1993) (2)
Fibrocystic Diseases of the Liver. Karen F. Murray and Anne M. Larson, editors. 640 pp. $239.00. Totowa, New Jersey, Humana Press. ISBN: 9-7816-0327-5231. Web address for ordering:www.springer.com (2011) (2)
157 – Hepatic Failure and Liver Transplantation (2012) (2)
Dual effects of hepatitis B (HBV) infection and hepatitis B immunoglobulin (HBIg) in reducing the incidence of acute rejection post-transplantation (1998) (2)
Current Issues in the Management of Hepatitis A and B (2007) (2)
Chronic hepatitis C in the human immunodeficiency virus-infected patient: management strategies. (2006) (2)
Role of emerging technology in the era of cost containment. (1997) (2)
Progressive asymptomatic occlusion of a TIPS in a patient with Budd-Chiari syndrome. (2006) (2)
Diagnosis of primary sclerosing cholangitis in a blood donor with elevated serum alanine aminotransferase. (1989) (2)
Update on liver transplantation. (2004) (2)
Gastroenterology in the 21st century--strength in unity: 1996 presidential address. (1996) (2)
Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case–control study (2012) (2)
Liver transplantation--challenges for the future. (1991) (1)
S2071 Vietnamese Patients with Chronic Hepatitis B (CHB) Exhibit Different Viral Genotype Distributions Than Chinese Patients (2008) (1)
Presidential address during the AGA Plenary Session. (2005) (1)
Liver transplantation at Stanford University Medical Center. (1998) (1)
62 Measuring Quality of Care in Patients with Cirrhosis: Development of An Explicit Quality Indicator Set (2009) (1)
Primary biliary cirrhosis: lessons learned from an organic-specific disease (2001) (1)
376 SYSTEMATIC REVIEW AND META-ANALYSIS: PREVALENCE OF SIGNIFICANT HISTOLOGIC DISEASE IN CHRONIC HEPATITIS B INFECTION, HIGH HBVDNA, AND PERSISTENTLY NORMAL SERUM ALT (PNALT) (2011) (1)
Chapter 5 – Laboratory Tests (2006) (1)
S2084 Significant Prevalence of Histologic Disease in Chronic Hepatitis B Patients with Mildly Elevated Serum Alanine Aminotrasferase Levels (2008) (1)
Best of DDW 2006. (2006) (1)
UpToDate Liver Practice Guidelines (2007) (1)
MELD Score: The Implementation of Evidence-based Selection Criteria for Allocation of Donor Livers A SPECIAL ARTICLE (2003) (1)
1214 DOSE-RELATED INCREASE IN VIROLOGIC RESPONSES USING CONTROLLED RELEASE NITAZOXANIDE PLUS PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 4: FINAL REPORT (2011) (1)
Hepatitis B Virus (HBV) Reverse Transcriptase Mutation Prevalence Was Low in Treatment-NaïVE Patients With Chronic Hepatitis B (CHB) Using Inno-Lipa HBV DR3 in a Prospective Multicenter Study (2011) (1)
Serum des-gamma-carboxyprothrombin for the screening of hepatocellular carcinoma in cirrhotic patients: A meta-analysis (2000) (1)
Update on chronic hepatitis C. (2003) (1)
Hepatitis C Virus Infection (2009) (1)
[Acute liver failure]. (2005) (1)
Predictive value of the timing of ALT and HCV RNA responses in defining patients who will have a virologic-sustained response after six months of interferon therapy (1998) (1)
Chronic Viral Hepatitis and Liver Transplantation (2002) (1)
S2077 Almost Half of the Chronic Hepatitis B (CHB) Patients with Positive HBeAg Have Confirmed Precore and/or Basal Core Promoter (PREC/BCP) Mutations (2008) (1)
PULSE OXIMETRY : TRAINING AND KNOWLEDGE. COMMENTARY (1998) (1)
Liver disease: hepatitis B. Treatment of chronic hepatitis B With entecavir. (2006) (1)
TREATMENT OF CHRONIC HEPATITIS B WITH ENTECAVIR: HIGH POTENCY AND ABSENT VIRAL RESISTANCE WITH 1 YEAR OF THERAPY (2006) (1)
Too many liver biopsies in patients with chronic hepatitis C (2001) (1)
Current perspectives: liver transplantation in the elderly (2005) (1)
Treatment of the hepatorenal syndrome (HRS) with dopamine (1974) (0)
hepatitis C virus infection Impaired dendritic cell maturation in patients with chronic, but not resolved, (2013) (0)
Management of hepatitis B in patients with HBeAg-negative disease (2007) (0)
636 High Rate of Complete Viral Suppression With Combination Therapy With Tenofovir Using Entecavir or Lamivudine/Emtricitabine in Patients With Chronic Hepatitis B and Prior Monotherapy Failure (2010) (0)
Reply of the authors: Liver Plasma Membrane Fluidity: An Important Factor in Bile Flow (1980) (0)
Emerging Hepatitis B Therapeutics (2005) (0)
Racial differences in risk for liver cancer in patients with hepatitis C cirrhosis: A multicenter case-control study (2003) (0)
M1892 Hepatitis B-E Antigen Positive (HBeAg+) Chronic Hepatitis B (CHB) Patients With Precore (PC) and Basic Core Promoter (BCP) Mutations (2010) (0)
Current Treatment of Chronic Hepatitis B (2009) (0)
Hepatitis B virus genotype: A missing link in transmission risk and disease progression? (2008) (0)
Liver transplantation and surgery (1992) (0)
M1786 Response to Peginterferon (PEG IFN) and Ribavirin (RBV) in Asian Americans and Non-Asian Americans with Chronic Hepatitis C (CHC) in a Real-Life Community Setting: A Multi-Center Study (2009) (0)
Chapter 31 – Liver transplantation (2004) (0)
Incidence and Predictors of Hepatitis B E Antigen (HBeAg) Seroconversion in Chronic Hepatitis B (CHB) Patients Treated With Anti-HBV Therapy in Routine Clinical Practice (2011) (0)
M1886 Transcatheter Arterial Chemoinfusion (TACI) Is Effective As a Bridge Towards Orthotopic Liver Transplantation and Downstaging to Maintain or Achieve Milan Criteria in Patients with Unresectable Hepatocellular Carcinoma (HCC) (2008) (0)
Hepatitis B and D Protocols (vol I & II) (2005) (0)
Approach to patients with HBV and HCV coinfection (2008) (0)
Comprar Handbook of Liver Disease, 3rd Edition Expert Consult - Online and Print | Emmet B. Keeffe | 9781437717259 | Saunders (2011) (0)
Differential response to treatment with consensus interferon (CIFN) and IFN alpha-2b in chronic HCV patients infected with different (1996) (0)
Outcomes of liver transplantation in patients with obesity and patients with inflammatory bowel disease. (2002) (0)
In Memoriam: Emmet B. Keeffe, MD (2011) (0)
TREATMENT OUTCOMES OF TRANSCATHETER ARTERIAL CHEMOINFUSION (TACI) IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC): 253 (2004) (0)
Special Issue: Pegylated interferon and ribavirin treatment for hepatitis C virus infection. (2010) (0)
Efficacy and Tolerability of Entecavir (ETV) after Liver Transplantation (LT) for Chronic Hepatitis B (CHB): 274 (2011) (0)
Diagnosis of sclerosing cholangitis (SC) by Tc-99m-disida SPECT imaging (1985) (0)
Incidence of Hepatitis B E Antigen (HBeAg) Seroconversion and Suboptimal Response in Chronic Hepatitis B (CHB) Patients Treated With Entecavir 0.5 mg Daily in Routine Clinical Practice (2011) (0)
Adefovir (ADV) Partial Response in Patients with Chronic Hepatitis B (CHB): Switch Versus Add-On Therapy: 275 (2011) (0)
High Rate of Recurrent Hepatitis B Viremia Following Treatment-Induced Hepatitis B E Antigen (HBeAg) Seroconversion (2011) (0)
HBV Precore C1858T Mutation Does Not Share Similar Clinical or Virologic Characteristics With Other Precore Mutants (2011) (0)
HEPATITIS C IS A MAJOR ETIOLOGY FOR HCC IN VIETNAMESE AMERICANS: 260 (2004) (0)
nitazoxanide combined with peginterferon and ribavirin for the treatment of chronic hepatitis C and very preliminary experiences with nitazoxanide for the treatment of chronic hepatitis B. ANTIVIRAL MECHANISM OF ACTION (2009) (0)
Sustained Virological Response to Interferon-Based Antiviral Therapy by Viral Genotype in Recurrent Hepatitis C Patients Following Liver Transplantation: 342 (2007) (0)
Book Reviews (1929) (0)
Liver Immunology (2003) (0)
Determinants of safe endoscopy. (1994) (0)
Current and Evolving Guidelines for the Treatment of Chronic Hepatitis C (2010) (0)
Access to Care and Optimal Treatment of Chronic Hepatitis B in Asian Americans: An Evolving Agenda (2011) (0)
Systematic Review and Meta-Analysis: Prevalence of Significant Histologic Disease in Chronic Hepatitis B Infection, High HBV DNA, and Persistently Normal Serum ALT (PNALT) (2011) (0)
Conferences and Reviews Controversies in Patient Selection for Liver Transplantation (0)
Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion. (1991) (0)
T1967 Asian Ethnicity is a Significant Predictor for Viral Dominance by HBV in HBV/HCV Co-Infected Patients: A Multicenter, Matched Case-Control Study (2010) (0)
A new and highly prevalent keratin mutation in patients with liver disease (2003) (0)
The evolving treatment of chronic hepatitis B : A clinical update (2007) (0)
Endoscopic management of gastrointestinal hemorrhage (1988) (0)
M1893 Hepatitis B Virus Reverse Transcriptase Mutations Were Not Detected in Treatment-NaïVE Patients With Chronic Hepatitis B Using Inno Lipa HBV DR3: A Prospective Multicenter Study (2010) (0)
Vaccination against hepatitis b in patients with chronic liver disease (2006) (0)
Medical Care of the Liver Transplant Patient (1998) (0)
Validation of an improved assay for ATPase activity in canaliculi-enriched liver plasma membranes (LPM) (1978) (0)
Best of DDW 2004: Highlights from the 2004 Digestive Disease Week (2004) (0)
Conferences and Reviews Hepatitis GVirus: IsitaHepatitis Virus? (1997) (0)
LEAD POISONING AS AN ETIOLOGY OF ABDOMINAL PAIN AND INTESTINAL PSEUDO-OBSTRUCTION IN ADULTS: 324 (2004) (0)
Life-Threatening Hepatic Failure Associated with Entecavir Resistance Mutations I269I/T and T184L Two Years after Discontinuation of Lamivudine: 560 (2007) (0)
WHAT THE GASTROENTEROLOGISTS KNOW THAT OTHERS MAY NOT (2002) (0)
301 INFRADURE: SUSTAINED INTERFERON-ALPHA (IFNα) PRODUCTION AND DELIVERY BY DERMAL MICROORGAN BIOPUMPS (2010) (0)
Prophylactic Tips for Large Gastric Varices: A Pilot Study with Four-Year Prospective Experience (2005) (0)
Hepatitis C: Clinic-Basic Interface (2005) (0)
Progress in liver diseases, Volume XI. Edited by J.L. Boyer and R.K. Ockner, 306 pp. Philadelphia: W.B. Saunders Co., 1993, $79 (1994) (0)
Getting to the cause of abnormal liver function test results (2007) (0)
Progress in liver diseases, volume XI Edited by J.L. Boyer and R.K. Ockner, 306 pp. Philadelphia: W.B. Saunders Co., 1993, $dollar;79 (1994) (0)
[Treatment of chronic hepatitis C with protease inhibitors: dawn of a new era]. (2010) (0)
A critical appraisal of current approaches to treatment of chronic hepatitis B (CHB)based on a review by an international panel of investigators and a survey of AASLD membership (2005) (0)
LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA AND THE ROLE OF PREOPERATIVE CHEMOEMBOLIZATION.: Abstract# 394 Poster Board #‐Session: P34‐II (2000) (0)
HBV viral kinetics and clinical management: key issues and current perspectives. Proceedings of a scientific and clinical expert panel meeting. Chicago, Illinois, USA, October 18, 2003. (2004) (0)
S2076 Age≥35 Years Is a Predictor of Significant Histology in Chronic Hepatitis B (CHB) Patients with Normal ALT Even with Stricter Cut-Offs (≤30 for Men and ≤19 for Women) (2008) (0)
Treatment of chronic hepatitis B with peginterferon. (2005) (0)
A Salute to the AGA Legacy Society (2016) (0)
Guide to Liver Transplantation, T.L. Fabry, F.M. Klion (Eds.). Igaku-Shoin, New York (1992), 334, $98.50 (1993) (0)
Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay. (1993) (0)
SCLEROTHERAPY AND CORTICOSTEROIDS : A WORD OF CAUTION. REPLY (1990) (0)
288 INFRADURE: SUSTAINED DELIVERY OF INTERFERON-ALPHA (IFNα) IN SCID MICE BY IMPLANTED IFNA SECRETING DERMAL BIOPUMPS (2010) (0)
S1280 Ethnicity, Alcohol Consumption, and Cigarette use as Predictors for Hepatocellular Carcinoma: A Prospective Study (2010) (0)
Training in endoscopic procedures. (1997) (0)
M2068 Correlation Between Serum Alpha-Fetoprotein and Alanine Aminotransferase Levels in Acute and Chronic Liver Disease (2009) (0)
S1900 Both Hepatitis C and B Virus Were Major Underlying Etiologies for Hepatocellular Carcinoma (HCC) in Vietnamese Americans While the Vast Majority of HCC Cases in Chinese Americans Were Associated With Hepatitis B Virus (2010) (0)
Diagnostic features of primary biliary cirrhosis compared with sclerosing cholangitis by technetium 99m diisopropyliminodiacetic acid scintigraphy (1986) (0)
Treatment of chronic hepatitis C in patients coinfected with human immunodeficiency virus and hepatitis C virus. (2005) (0)
Hepatitis C Virus (2005) (0)
Liver transplantation (1996) (0)
Abstract No. 190: Chemoembolization Downstaging of Hepatocellular Carcinoma for Liver Transplantation (2009) (0)
Upodate on chronic hepatitis C (2003) (0)
Don't forget vaccination against hepatitis A and B in patients with chronic hepatitis C.* (2001) (0)
Ethnic Differences in Etiology, Staging and Treatment Eligibility of Patients With Hepatocellular Carcinoma (HCC) (2011) (0)
Hepatitis B Vaccination: Current and Evolving Recommendations (2011) (0)
Predictors of Long Term Outcome Following Transjugular Intrahepatic Portosystemic Shunt (TIPS): 420 (2008) (0)
DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS (PBC), SCLEROSING CHOLANGITIS (SC), AND ISOLATED COMMON BILE DUCT OBSTRUCTION (ICBDO) BY Tc‐99m‐IDA SCINTIGRAPHY: P11 (1986) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Emmet B. Keeffe?

Emmet B. Keeffe is affiliated with the following schools:

Stanford University